Breast CancerNCT06455657

Breast Cancer Education to Prisoner Women

A study testing breast cancer education in people with Breast Cancer, run by Hitit University at 3 sites in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record

Search all trials

Trial summary

this study evaluated the impact of breast cancer education on knowledge and awareness among incarcerated women using a quasi-experimental design. Read more about this study

Who is it for?: Ages 18 to 65 years, women only
Conditions the study is for: Breast Cancer
What is being tested?: breast cancer education
Could I receive a placebo?: No, everyone receives an active treatment
How many people: 40 participants
Where: 3 sitesTurkey (Türkiye)
Study dates: 24 May 2024to 15 Aug 2024
Phase: Interventional
Are there results?: None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

Ages 18 to 65 years
Women only
No healthy volunteers
Adult, Older adult

Who may be able to join

Volunteering to participate in the study,
Being between the ages of 18-65,
No history of breast cancer,
To know Turkish.

Who cannot join

Those who do not agree to participate in the study,
Having a history of breast cancer,
Those who do not speak Turkish

Trial locations and contacts

3 sites in 1 country.

Turkey (Türkiye)3 sites

Hitit university
Çorum
Fatma Yıldırım
Çorum, Çorum, 19600
L type prison
Çorum, Çorum, 19600

Other trials in Turkey (Türkiye)

About this study

Official title: Breast Cancer Education for Prisoner Women

this study evaluated the impact of breast cancer education on knowledge and awareness among incarcerated women using a quasi-experimental design.

Read the detailed description

this study evaluated the impact of breast cancer education on knowledge and awareness among incarcerated women using a quasi-experimental design.

Conditions: Breast Cancer
Being tested: breast cancer education
Medical subject headings: Breast Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

breast cancer educationOther
Questionnaires and scales will be administered to the participants as a pre-test. Breast cancer education will be provided in groups and their feedback will be received. Reminder training will be repeated 1 month after the training. The survey and scales will be administered to the participants as a posttest 1 month after the second training.

Study groups in NCT06455657
Study group	Role	What they receive
Prisoner women receiving breast cancer training	Experimental	Questionnaires and scales will be administered to the participants as a pre-test. Breast cancer education will be provided in groups and their feedback will be received. Reminder training will be repeated 1 month after the training. The survey and scales will be administered to the participants as a posttest 1 month after the second training. Receives: Other: breast cancer education

What is being measured

The primary outcome is the main question the study is designed to answer.

Breast Cancer Awareness Scale
The scale is used to measure breast cancer awareness by assessing knowledge of symptoms, appropriate age-related risk, and breast self-examination practices. Higher total scores reflect higher awareness levels.
Measured: first-2. months

Secondary outcomes (1)

Comprehensive Breast Cancer Knowledge Test
The scale is used to evaluate breast cancer knowledge and perceptions of treatability through true-false statements, with higher scores reflecting greater knowledge levels.
Measured: first- 2. months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

24 May 202415 Aug 2024

First posted12 Jun 2024
Study start24 May 2024
Primary completion15 Aug 2024
Study completion15 Aug 2024

Resources

Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
Publications (7)Papers the sponsor has linked to this study.
Other trials for Breast CancerStudies of the same condition, open and under way.
What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design

Study type: Interventional
Phase: Phase N/A
Primary purpose: Health services research
Allocation: Not applicable
Intervention model: Single group
Model description: The study is of a semi-separate type and all women can be trained.
Masking: None (open label)
Enrolment: 40 participants (actual)

IDs, dates and publications

ClinicalTrials.gov ID: NCT06455657
Sponsor's protocol ID: Hitit_university_1
Status last verified: Jan 2026
First submitted: 23 May 2024
Last updated: 4 Jun 2026
Results posted: No
Data monitoring committee: No
FDA-regulated drug: No
FDA-regulated device: No
Individual data sharing: No

Publications

Black E, Richmond R. Improving early detection of breast cancer in sub-Saharan Africa: why mammography may not be the way forward. Global Health. 2019 Jan 8;15(1):3. doi: 10.1186/s12992-018-0446-6.
PubMed 30621753
Choi JS, Park M. Factors predicting young women's willingness to conduct vulvar self-examinations in Korea. Health Care Women Int. 2019 Jun;40(6):653-664. doi: 10.1080/07399332.2018.1531003. Epub 2018 Dec 14.
PubMed 30550371
Jemal A, Bray F, Forman D, O'Brien M, Ferlay J, Center M, Parkin DM. Cancer burden in Africa and opportunities for prevention. Cancer. 2012 Sep 15;118(18):4372-84. doi: 10.1002/cncr.27410. Epub 2012 Jan 17.
PubMed 22252462
Mohamed, A. O. A., Nori, M. M. M., & Altamih, R. A. A. (2021). The Effectiveness of Breast Cancer Health Education Campaign and Breast Self-Examination Training among Female Detainees, Khartoum City-Sudan. Journal of Environmental Science and Public Health, 5(2), 296-310
Saadeldin A. Idris, Aamir A. Hamza, Mohamed M. Hafiz, Mohammed Eltayeb A. Ali, Gamal E. H. A., El Shallaly Knowledge, attitude and practice of breast self examination among final years female medical students in Sudan. Int J Public Health Res 2013;1:6-10
American Cancer Society. Breast Cancer Information & Overview. 2023. Available from: https://www.cancer.org/cancer/types/breast-cancer.html
Baş, S., Ursavaş, F.(2022). Meme Kanseri Farkındalık Ölçeğinin Geçerlilik ve Güvenilirliği, Çankırı Karatekin Üniversitesi Sağlık Bilimleri Enstitüsü Hemşirelik Anabilim Dalı, Yüksek Lisans Tezi

Want to know more?

The sponsor has not listed a contact. The official record may have more details.

Talk to your doctor first and take this page with you. Only the study team can confirm whether you can join.

Questions to ask the study team

What is the study trying to find out?
What would I need to do, and how often would I visit?
Could I receive a placebo instead of the treatment?
What are the possible risks and benefits for me?
Will it cost me anything? Are travel or time paid for?
Can I keep seeing my own doctor during the study?
What happens when the study ends?

See locations

Active, not recruiting
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Breast Cancer, Comorbidities and Coexisting Conditions
RecruitingPhase 2
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
Invasive Mammary Carcinoma, Metastatic Breast Cancer
Not yet recruitingObservational study
Comparison of Reliability, Time Cost, and Participant Comfort of Lymphedema Assessments in Upper Extremity
Lymphedema, Upper Extremity Lymphedema
RecruitingPhase 3
A Study of Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (BCTOP-T-N01)
TNBC - Triple-Negative Breast Cancer
RecruitingPhase 3
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8

All Breast Cancer trials

Study at a glance

From the registry record, last updated by the sponsor on 4 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.

Official title: Breast Cancer Education for Prisoner Women
ClinicalTrials.gov ID: NCT06455657
Acronym / sponsor ID: Hitit_university_1
Conditions: Breast Cancer
Study type: Interventional
Recruitment status: Completed
Enrolment: 40 participants (actual)
Lead sponsor: Hitit UniversityUniversity, hospital or other
Study start: 24 May 2024 (actual)
Primary completion: 15 Aug 2024 (actual)
Study completion: 15 Aug 2024 (actual)
First posted: 12 Jun 2024 (actual)
Results: Not posted in the source record

Clinical summary

The research question as the sponsor registered it. This describes what the study plans to test, not what it found.

this study evaluated the impact of breast cancer education on knowledge and awareness among incarcerated women using a quasi-experimental design.

Detailed description

this study evaluated the impact of breast cancer education on knowledge and awareness among incarcerated women using a quasi-experimental design.

Study design

Primary purpose: Health services research
Allocation: Not applicable
Intervention model: Single group
Masking: None (open label)
Number of arms: 1
Model description: The study is of a semi-separate type and all women can be trained.

Arm	Type	Receives
Prisoner women receiving breast cancer training	Experimental	Other: breast cancer educationQuestionnaires and scales will be administered to the participants as a pre-test. Breast cancer education will be provided in groups and their feedback will be received. Reminder training will be repeated 1 month after the training. The survey and scales will be administered to the participants as a posttest 1 month after the second training.

Who may qualify

Ages: 18 to 65 years
Sex: Female only
Healthy volunteers: Not accepted
Age groups: Adult, Older adult

Key inclusion criteria (4 listed)

Volunteering to participate in the study,
Being between the ages of 18-65,
No history of breast cancer,
To know Turkish.

Key exclusion criteria (3 listed)

Those who do not agree to participate in the study,
Having a history of breast cancer,
Those who do not speak Turkish

Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.

Interventions

Intervention	Type	Arms
breast cancer educationQuestionnaires and scales will be administered to the participants as a pre-test. Breast cancer education will be provided in groups and their feedback will be received. Reminder training will be repeated 1 month after the training. The survey and scales will be administered to the participants as a posttest 1 month after the second training.	Other	Prisoner women receiving breast cancer training

Primary outcome

Breast Cancer Awareness Scale
Time frame: first-2. months
The scale is used to measure breast cancer awareness by assessing knowledge of symptoms, appropriate age-related risk, and breast self-examination practices. Higher total scores reflect higher awareness levels.

1 secondary outcome

Comprehensive Breast Cancer Knowledge Test
Time frame: first- 2. months

Results and safety

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

Research links

Official record on ClinicalTrials.govLast updated by the sponsor 4 Jun 2026.
Background: PubMed 30621753Black E, Richmond R. Improving early detection of breast cancer in sub-Saharan Africa: why mammography may not be the way forward. Global Health. 2019 Jan 8;15(1):3. doi: 10.1186/s12992-018-0446-6.
Background: PubMed 30550371Choi JS, Park M. Factors predicting young women's willingness to conduct vulvar self-examinations in Korea. Health Care Women Int. 2019 Jun;40(6):653-664. doi: 10.1080/07399332.2018.1531003. Epub 2018 Dec 14.
Background: PubMed 22252462Jemal A, Bray F, Forman D, O'Brien M, Ferlay J, Center M, Parkin DM. Cancer burden in Africa and opportunities for prevention. Cancer. 2012 Sep 15;118(18):4372-84. doi: 10.1002/cncr.27410. Epub 2012 Jan 17.
BackgroundMohamed, A. O. A., Nori, M. M. M., & Altamih, R. A. A. (2021). The Effectiveness of Breast Cancer Health Education Campaign and Breast Self-Examination Training among Female Detainees, Khartoum City-Sudan. Journal of Environmental Science and Public Health, 5(2), 296-310
BackgroundSaadeldin A. Idris, Aamir A. Hamza, Mohamed M. Hafiz, Mohammed Eltayeb A. Ali, Gamal E. H. A., El Shallaly Knowledge, attitude and practice of breast self examination among final years female medical students in Sudan. Int J Public Health Res 2013;1:6-10
Results publicationAmerican Cancer Society. Breast Cancer Information & Overview. 2023. Available from: https://www.cancer.org/cancer/types/breast-cancer.html
Results publicationBaş, S., Ursavaş, F.(2022). Meme Kanseri Farkındalık Ölçeğinin Geçerlilik ve Güvenilirliği, Çankırı Karatekin Üniversitesi Sağlık Bilimleri Enstitüsü Hemşirelik Anabilim Dalı, Yüksek Lisans Tezi
Individual participant dataSharing planned: No

Related trials for Breast Cancer

Active, not recruiting
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Breast Cancer, Comorbidities and Coexisting Conditions
RecruitingPhase 2
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
Invasive Mammary Carcinoma, Metastatic Breast Cancer
Not yet recruitingObservational study
Comparison of Reliability, Time Cost, and Participant Comfort of Lymphedema Assessments in Upper Extremity
Lymphedema, Upper Extremity Lymphedema
RecruitingPhase 3
A Study of Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (BCTOP-T-N01)
TNBC - Triple-Negative Breast Cancer
RecruitingPhase 3
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8

Referral and contact

AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.

The record lists no contact. Use the official record to reach the sponsor.

3 sites in 1 country: see every site and its status.

Questions about this trial

What is this clinical trial studying?

A study testing breast cancer education in people with Breast Cancer, run by Hitit University at 3 sites in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Breast Cancer Awareness Scale (time frame: first-2. months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06455657, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Jun 2026; AzTrials last refreshed its copy on 7 Nov 2026.